ArticleInflammation2025
Expression and regulation network of BLNK in CP/CPPS in animal, cell model and clinical samples.
Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
B-cell linker (BLNK) is associated with the inflammatory process of certain diseases. However, no studies have explored the role of BLNK in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We performed transcriptome analysis of the rat model and found that BCR signaling pathway, especially the BLNK gene, is closely related to CP/CPPS. We detected the expression levels of BLNK gene or protein in CP/CPPS rat tissues, human expressed prostatic secretion (EPS), and cell models by qPCR, WB, and IHC. Subsequently, we silenced the BLNK gene in human prostatitis cell model. The cell cycle, and expression level of inflammatory factors were detected; the core pathway and interacting molecules of BLNK were revealed by mRNA/lncRNA sequencing, bioinformatics analysis and validation. Results showed that the BLNK gene or protein was significantly upregulated in the CP/CPPS rat tissues, human EPS, and cell model. Functionally, BLNK silencing inhibited the proliferation, promoted cell apoptosis and S phase arrest, and inhibited the expression of IL-1β, IL-6, and IL-8 at the human prostatitis cell model. Furthermore, the DEGs and DE-lncRNA induced by BLNK silencing were significantly enriched in the calcium signaling pathway, the BLNK has strongly interacted with EDNRB, FGF1, FGF2, and F2R. Moreover, in prostatitis group, all four genes are target genes of LINC02518, and their expression levels were significantly altered after BLNK silencing. These results suggest the important role of BLNK in CP/CPPS. BLNK may affect the proliferation and inflammatory factor secretion of CP/CPPS through calcium signaling pathway, which may be closely related to LINC02518.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.